# SBIG Holdings, Inc.: financial statements, quarterly

SBIG · OTC · CIK 1801602 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sbig.md) · [Financials](/companies/sbig/financials.md) · [Filings](/companies/sbig/filings.md) · [Insiders](/companies/sbig/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sbig/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [6,888](/filings/0001628280-23-038706.md) | [6,791 d](/filings/0001628280-24-013998.md) | [6,474](/filings/0001628280-24-023235.md) | [6,612](/filings/0001213900-24-068301.md) | [6,144](/filings/0001213900-25-110172.md) | [5,687 d](/filings/0001213900-26-034944.md) | [5,516](/filings/0001213900-26-056127.md) | [5,837](/filings/0001213900-26-091690.md) | [5,871](/filings/0001213900-25-110172.md) | [5,613 d](/filings/0001213900-26-034944.md) | [5,444](/filings/0001213900-26-056127.md) | [4,429](/filings/0001213900-26-091690.md) |
| Cost of revenue | $k | [1,604](/filings/0001213900-24-097606.md) | [2,021 d](/filings/0001013762-25-003507.md) | [1,716](/filings/0001213900-25-042867.md) | [1,725](/filings/0001213900-25-075869.md) | [1,709](/filings/0001213900-25-110172.md) | [1,505 d](/filings/0001213900-26-034944.md) | [1,206](/filings/0001213900-26-056127.md) | [1,499](/filings/0001213900-26-091690.md) | [1,729](/filings/0001213900-25-110172.md) | [2,414 d](/filings/0001213900-26-034944.md) | [1,858](/filings/0001213900-26-056127.md) | [1,568](/filings/0001213900-26-091690.md) |
| Gross profit | $k | [5,284](/filings/0001213900-24-097606.md) | [4,770 d](/filings/0001013762-25-003507.md) | [4,680](/filings/0001213900-25-042867.md) | [4,697](/filings/0001213900-25-075869.md) | [4,435](/filings/0001213900-25-110172.md) | [4,182 d](/filings/0001213900-26-034944.md) | [4,310](/filings/0001213900-26-056127.md) | [4,338](/filings/0001213900-26-091690.md) | [4,142](/filings/0001213900-25-110172.md) | [3,199 d](/filings/0001213900-26-034944.md) | [3,586](/filings/0001213900-26-056127.md) | [2,861](/filings/0001213900-26-091690.md) |
| Research and development | $k | [1,912](/filings/0001213900-24-097606.md) | [1,754 d](/filings/0001013762-25-003507.md) | [1,666](/filings/0001213900-25-042867.md) | [1,270](/filings/0001213900-25-075869.md) | [1,640](/filings/0001213900-25-110172.md) | [1,325 d](/filings/0001213900-26-034944.md) | [1,271](/filings/0001213900-26-056127.md) | [1,233](/filings/0001213900-26-091690.md) | [1,100](/filings/0001213900-25-110172.md) | [1,160 d](/filings/0001213900-26-034944.md) | [1,229](/filings/0001213900-26-056127.md) | [972](/filings/0001213900-26-091690.md) |
| Operating income | $k | [(2,692)](/filings/0001213900-24-097606.md) | [(2,147) d](/filings/0001013762-25-003507.md) | [(282)](/filings/0001213900-25-042867.md) | [(57.0)](/filings/0001213900-25-075869.md) | [(45.0)](/filings/0001213900-25-110172.md) | [(216) d](/filings/0001213900-26-034944.md) | [(427)](/filings/0001213900-26-056127.md) | [(726)](/filings/0001213900-26-091690.md) | [563](/filings/0001213900-25-110172.md) | [(1,136) d](/filings/0001213900-26-034944.md) | [(139)](/filings/0001213900-26-056127.md) | [(19.0)](/filings/0001213900-26-091690.md) |
| Interest expense | $k | [400](/filings/0001213900-24-097606.md) | [1,133 d](/filings/0001013762-25-003507.md) | [875](/filings/0001213900-25-042867.md) | [544](/filings/0001213900-24-068301.md) | [550](/filings/0001213900-24-097606.md) | [239 d](/filings/0001213900-26-034944.md) | [324](/filings/0001213900-26-056127.md) | [317](/filings/0001213900-26-091690.md) | [335](/filings/0001213900-25-110172.md) | [348 d](/filings/0001213900-26-034944.md) | [355](/filings/0001213900-26-056127.md) | [2,340](/filings/0001213900-26-091690.md) |
| Income tax | $k | [0.0](/filings/0001628280-23-038706.md) | [4.0 d](/filings/0001013762-25-003507.md) | [0.0](/filings/0001628280-24-023235.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(2,742)](/filings/0001213900-24-097606.md) | [(3,201) d](/filings/0001013762-25-003507.md) | [417](/filings/0001213900-25-042867.md) | [(647)](/filings/0001213900-25-075869.md) | [(554)](/filings/0001213900-25-110172.md) | [(1,092) d](/filings/0001213900-26-034944.md) | [(751)](/filings/0001213900-26-056127.md) | [(1,141)](/filings/0001213900-26-091690.md) | [219](/filings/0001213900-25-110172.md) | [(1,574) d](/filings/0001213900-26-034944.md) | [(494)](/filings/0001213900-26-056127.md) | [(2,353)](/filings/0001213900-26-091690.md) |
| Diluted EPS | $ per share | [(0.07)](/filings/0001213900-24-097606.md) | not reported | [0.01](/filings/0001213900-25-042867.md) | [(0.01)](/filings/0001213900-25-075869.md) | [(0.01)](/filings/0001213900-25-110172.md) | not reported | [(0.02)](/filings/0001213900-26-056127.md) | [(0.02)](/filings/0001213900-26-091690.md) | [0.00](/filings/0001213900-25-110172.md) | not reported | [(0.01)](/filings/0001213900-26-056127.md) | [(0.05)](/filings/0001213900-26-091690.md) |
| Basic EPS | $ per share | [(0.07)](/filings/0001213900-24-097606.md) | not reported | [0.01](/filings/0001213900-25-042867.md) | [(0.01)](/filings/0001213900-25-075869.md) | [(0.01)](/filings/0001213900-25-110172.md) | not reported | [(0.02)](/filings/0001213900-26-056127.md) | [(0.02)](/filings/0001213900-26-091690.md) | [0.00](/filings/0001213900-25-110172.md) | not reported | [(0.01)](/filings/0001213900-26-056127.md) | [(0.05)](/filings/0001213900-26-091690.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.3](/filings/0001628280-23-038706.md) | [0.3](/filings/0001013762-25-003507.md) | [1.7](/filings/0001628280-24-023235.md) | [0.7](/filings/0001213900-24-068301.md) | [0.8](/filings/0001213900-24-097606.md) | [1.2](/filings/0001213900-26-034944.md) | [1.1](/filings/0001213900-25-042867.md) | [1.4](/filings/0001213900-25-075869.md) | [1.5](/filings/0001213900-25-110172.md) | [1.5](/filings/0001213900-26-034944.md) | [1.3](/filings/0001213900-26-056127.md) | [0.3](/filings/0001213900-26-091690.md) |
| Current assets | $m | [5.7](/filings/0001628280-23-038706.md) | [4.4](/filings/0001013762-25-003507.md) | [5.7](/filings/0001628280-24-023235.md) | [4.7](/filings/0001213900-24-068301.md) | [4.4](/filings/0001213900-24-097606.md) | [3.9](/filings/0001213900-26-034944.md) | [4.0](/filings/0001213900-25-042867.md) | [4.1](/filings/0001213900-25-075869.md) | [4.7](/filings/0001213900-25-110172.md) | [4.2](/filings/0001213900-26-091690.md) | [3.9](/filings/0001213900-26-056127.md) | [2.5](/filings/0001213900-26-091690.md) |
| Total assets | $m | [6.9](/filings/0001628280-23-038706.md) | [5.1](/filings/0001013762-25-003507.md) | [9.1](/filings/0001628280-24-023235.md) | [7.9](/filings/0001213900-24-068301.md) | [7.5](/filings/0001213900-24-097606.md) | [6.8](/filings/0001213900-26-034944.md) | [6.9](/filings/0001213900-25-042867.md) | [4.6](/filings/0001213900-25-075869.md) | [5.2](/filings/0001213900-25-110172.md) | [4.6](/filings/0001213900-26-091690.md) | [4.3](/filings/0001213900-26-056127.md) | [2.9](/filings/0001213900-26-091690.md) |
| Current liabilities | $m | [12.5](/filings/0001628280-23-038706.md) | [13.6](/filings/0001013762-25-003507.md) | [7.1](/filings/0001628280-24-023235.md) | not reported | [13.7](/filings/0001213900-24-097606.md) | [5.7](/filings/0001213900-26-034944.md) | [6.1](/filings/0001213900-25-042867.md) | [7.0](/filings/0001213900-25-075869.md) | [6.7](/filings/0001213900-25-110172.md) | [7.7](/filings/0001213900-26-091690.md) | [17.1](/filings/0001213900-26-056127.md) | [18.0](/filings/0001213900-26-091690.md) |
| Total liabilities | $m | [12.7](/filings/0001628280-23-038706.md) | [13.8](/filings/0001013762-25-003507.md) | [17.1](/filings/0001628280-24-023235.md) | [16.4](/filings/0001213900-24-068301.md) | [16.3](/filings/0001213900-24-097606.md) | [16.6](/filings/0001213900-26-034944.md) | [17.2](/filings/0001213900-25-042867.md) | [16.0](/filings/0001213900-25-075869.md) | [16.1](/filings/0001213900-25-110172.md) | [17.1](/filings/0001213900-26-091690.md) | [17.2](/filings/0001213900-26-056127.md) | [18.1](/filings/0001213900-26-091690.md) |
| Long-term debt | $m | not reported | [13.6](/filings/0001213900-24-068301.md) | [7.2](/filings/0001628280-24-023235.md) | [13.6](/filings/0001213900-24-068301.md) | [7.7](/filings/0001213900-24-097606.md) | [8.4](/filings/0001213900-26-034944.md) | [8.7](/filings/0001213900-25-042867.md) | [8.7](/filings/0001213900-25-075869.md) | [9.2](/filings/0001213900-25-110172.md) | [9.2](/filings/0001213900-26-034944.md) | [9.8](/filings/0001213900-26-056127.md) | [9.8](/filings/0001213900-26-091690.md) |
| Current portion of debt | $m | [4.6](/filings/0001628280-23-038706.md) | [4.4](/filings/0001013762-25-003507.md) | [0.0](/filings/0001628280-24-023235.md) | [7.4](/filings/0001213900-24-068301.md) | [7.7](/filings/0001213900-24-097606.md) | not reported | not reported | not reported | not reported | not reported | [9.8](/filings/0001213900-26-056127.md) | [9.8](/filings/0001213900-26-091690.md) |
| Short-term borrowings | $m | not reported | [1.9](/filings/0001013762-25-003507.md) | not reported | [0.5](/filings/0001213900-24-068301.md) | [0.0](/filings/0001213900-24-097606.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [(5.9)](/filings/0001213900-24-097606.md) | [(8.7)](/filings/0001213900-26-034944.md) | [(8.0)](/filings/0001213900-25-075869.md) | [(8.5)](/filings/0001213900-25-110172.md) | [(8.8)](/filings/0001213900-25-110172.md) | [(9.8)](/filings/0001213900-26-091690.md) | [(10.4)](/filings/0001213900-26-091690.md) | [(11.3)](/filings/0001213900-26-091690.md) | [(11.0)](/filings/0001213900-25-110172.md) | [(12.5)](/filings/0001213900-26-091690.md) | [(12.9)](/filings/0001213900-26-091690.md) | [(15.2)](/filings/0001213900-26-091690.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(905) d](/filings/0001213900-24-097606.md) | [(508) d](/filings/0001013762-25-003507.md) | [(1,878)](/filings/0001213900-25-042867.md) | [(41.0) d](/filings/0001213900-25-075869.md) | [585 d](/filings/0001213900-25-110172.md) | [381 d](/filings/0001213900-26-034944.md) | [(86.0)](/filings/0001213900-26-056127.md) | [218](/filings/0001213900-25-075869.md) | [163 d](/filings/0001213900-25-110172.md) | [(20.0) d](/filings/0001213900-26-034944.md) | [(229)](/filings/0001213900-26-056127.md) | [(928) d](/filings/0001213900-26-091690.md) |
| Capital expenditure | $k | [165 d](/filings/0001213900-24-097606.md) | [102 d](/filings/0001013762-25-003507.md) | [59.0](/filings/0001213900-25-042867.md) | [4.0 d](/filings/0001213900-25-075869.md) | [1.0 d](/filings/0001213900-25-110172.md) | [0.0 d](/filings/0001213900-26-034944.md) | [6.0](/filings/0001213900-26-056127.md) | [8.0 d](/filings/0001213900-26-091690.md) | [14.0 d](/filings/0001213900-25-110172.md) | [12.0 d](/filings/0001213900-26-034944.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [25.6](/filings/0001628280-23-038706.md) | [26.8](/filings/0001628280-24-023235.md) | [31.5](/filings/0001213900-24-068301.md) | [41.9](/filings/0001213900-24-097606.md) | [77.3](/filings/0001213900-25-042867.md) | [45.7](/filings/0001213900-25-075869.md) | [46.3](/filings/0001213900-25-110172.md) | [46.4](/filings/0001213900-26-056127.md) | [46.8](/filings/0001213900-26-091690.md) | [47.8](/filings/0001213900-25-110172.md) | [48.6](/filings/0001213900-26-056127.md) | [48.8](/filings/0001213900-26-091690.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 48,795,266 at 2026-07-14, from the cover of the [10-Q filed 2026-08-19](/filings/0001213900-26-091690.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.